Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMD - Age-Related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02088151
What this trial is testing

Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Who this might be right for
Macular EdemaCentral Serous ChorioretinopathyRetinal Vein Occlusion+2 more
Insel Gruppe AG, University Hospital Bern 18
Early research (Phase 1)Study completedNCT01922128
What this trial is testing

Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

Who this might be right for
Nonexudative Age-related Macular Degeneration
MacuCLEAR, Inc. 20
Not applicableUnknownNCT00443911
What this trial is testing

Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 20
Large-scale testing (Phase 3)Looking for participantsNCT07189169
What this trial is testing

QA108 Phase III Study in Subjects With Intermediate AMD

Who this might be right for
Intermediate Age-Related Macular Degeneration
Smilebiotek Zhuhai Limited 400
Testing effectiveness (Phase 2)Study completedNCT00376701
What this trial is testing

Combination Therapy for Age-Related Macular Degeneration.

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Not applicableStudy completedNCT05542381
What this trial is testing

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

Who this might be right for
Age-Related Macular Degeneration
Virginia Polytechnic Institute and State University 64
Large-scale testing (Phase 3)Study completedNCT00637377
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Bayer 1,240
Large-scale testing (Phase 3)Study completedNCT04777201
What this trial is testing

Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche 1,036
Not applicableUnknownNCT00455871
What this trial is testing

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Who this might be right for
Age-Related Macular Degeneration
Barnes Retina Institute 30
Not applicableStudy completedNCT04455399
What this trial is testing

Time Efficiency Comparison of Two IntraVitreal Injection Techniques

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion With Macular Edema+2 more
Peregrine Eye and Laser Institute 200
Large-scale testing (Phase 3)Study completedNCT00509795
What this trial is testing

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 1,217
Not applicableStudy completedNCT00527553
What this trial is testing

The Effect of Eggs and Egg Products on Macular Pigment

Who this might be right for
Age-related Macular Degeneration
Maastricht University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT02732899
What this trial is testing

Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD

Who this might be right for
Exudative Age Related Macular Degeneration
Maturi, Raj K., M.D., P.C. 20
Testing effectiveness (Phase 2)UnknownNCT00745511
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Ora Bio Ltd. 96
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Large-scale testing (Phase 3)WithdrawnNCT00557791
What this trial is testing

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)

Who this might be right for
Age Related Macular Degeneration
OPKO Health, Inc.
Post-approval studies (Phase 4)Study completedNCT03355638
What this trial is testing

Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3

Who this might be right for
Macular Edema
Università degli Studi di Brescia 60
Not applicableStudy completedNCT01915238
What this trial is testing

Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study

Who this might be right for
AMDAge- Related Macular Degeneration
National Eye Institute (NEI) 52
Testing effectiveness (Phase 2)Study completedNCT02181504
What this trial is testing

Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 25
Not applicableEnrolling By InvitationNCT06682455
What this trial is testing

Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)

Who this might be right for
Age-Related Macular Degeneration
University of Southampton 300
Next Page